PT-141 Peptide |Bremelanotide Melanocortin Peptide

PT-141 Peptide |Bremelanotide Melanocortin Peptide

Blog Article

PT-141 Peptide, also known as Bremelanotide, is a synthetic melanocortin-receptor agonist peptide that has been researched for its effects on sexual desire and arousal pathways. It acts on melanocortin receptors in the nervous system rather than functioning as a testosterone or hormone replacement product.

Bremelanotide is the active ingredient in Bremelanotide Melanocortin Peptide an FDA-approved prescription medicine for a specific sexual desire disorder in premenopausal women. However, research-grade PT-141 products sold separately may not have the same formulation, approval, quality controls, or approved indications.

Product Highlights

Contains PT-141 Peptide

Synthetic melanocortin peptide

Studied in relation to sexual desire and arousal pathways

Acts through melanocortin receptors

Suitable for research-focused peptide collections where permitted

Potential Benefits:

Sexual desire: Bremelanotide is FDA-approved in the U.S. for acquired, generalized HSDD in certain premenopausal women.

Sexual arousal: It acts on melanocortin receptors involved in sexual-response pathways.

Libido research: PT-141 has been studied for effects on sexual motivation and desire in both male and female populations.

Non-hormonal mechanism: Unlike testosterone products, PT-141 works through melanocortin-receptor signaling rather than replacing sex hormones.

Research Information

PT-141 has been investigated for its influence on melanocortin signaling and sexual-response pathways. Research has also explored its potential effects in both male and female sexual-function contexts.

Report this page